Halozyme Therapeutics, Inc. · NASDAQ:HALO

Krishnan Mahesh received 3,796 Halozyme Therapeutics, Inc. shares as an award (Form 4)

Traded May 5, 2026 · Filed May 7, 2026

On May 5, 2026, Krishnan Mahesh (Director) received 3,796 Halozyme Therapeutics, Inc. shares as an award, leaving 14,462 shares. Filed May 7, 2026 (Form 4).

Awarded
3,796 shares
Holding after
14,462 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 5, 2026Common StockAward3,79614,462Direct

Source

View original at SEC

Related